The business model of 908 Devices Inc. focuses on developing and providing innovative analytical devices for chemical and biomolecular analysis. The company specializes in creating handheld and desktop mass spectrometry instruments that enable real-time, on-site analysis. These devices are designed to deliver accurate and reliable results in various applications such as safety and security, life sciences, and research. 908 Devices Inc. aims to empower scientists, researchers, and field workers with efficient and flexible tools for qualitative and quantitative analysis, ensuring faster decision-making processes and improved productivity in their respective industries.

908 Devices Inc. is primarily active in the industries of chemical, life sciences, and safety and security.

The main competitors of 908 Devices Inc. in the market include companies such as Agilent Technologies, PerkinElmer, Thermo Fisher Scientific, Waters Corporation, and Bruker Corporation.

908 Devices Inc. is a leading provider of mass spectrometry solutions. Founded in 2012, the company is based in Boston, Massachusetts. With a strong focus on delivering innovative chemical analysis tools, 908 Devices Inc. has developed cutting-edge technologies that enable reliable and fast chemical analysis both in the lab and in the field. Their portable and handheld devices are widely used for applications including safety and security, life sciences, and first responder efforts. With a commitment to pushing the boundaries of analytical capabilities, 908 Devices Inc. continues to revolutionize the field of mass spectrometry through their advanced and user-friendly solutions.

Some significant milestones achieved by 908 Devices Inc. include the successful development and launch of their flagship product, the M908™ handheld mass spectrometer, which revolutionized chemical analysis in the field; their collaboration with federal and local law enforcement agencies to enhance security and threat detection capabilities; and their expansion into new markets and industries, such as forensics, environmental analysis, and safety and security. The company has also received numerous awards and recognition for their innovative technologies and contributions to the scientific community.

908 Devices Inc. is primarily present in the United States and Canada.

908 Devices Inc. represents a commitment to advancing science and public safety through innovative technologies. The company focuses on developing and commercializing purpose-built devices for chemical analysis, enabling first responders and scientists to make informed decisions quickly and accurately. 908 Devices Inc. values collaboration, driven by a passion for addressing real-world challenges in research, life sciences, and safety and security industries. With a customer-centric approach, the company strives to deliver solutions that empower users with actionable insights. The corporate philosophy of 908 Devices Inc. revolves around pushing the boundaries of science and using technology to enhance the well-being of society.

Analysts currently set an average price target of 10,20 USD for the 908 Devices stock (median: 10,20 USD), implying +33,9 % versus the latest price. The consensus is based on 10 analyst ratings.

908 Devices Analyytikkojen kursstavoitteet 2026

10 analysts currently rate the 908 Devices stock: 9 recommend buying, 1 holding and 0 selling. For 2026, analysts expect 908 Devices to generate revenue of 68,53 M USD and earnings per share of −0,37 USD.

908 Devices Analyytikkojen kursstavoitteet 2026

Converted at the current exchange rate, the 908 Devices share trades at 6,62 EUR (7,62 USD).

The 908 Devices share (MASS) is listed on 1 stock exchanges, including: NASDAQ (MASS).

The company 908 Devices Inc. specializes in manufacturing portable devices for chemical analysis. They offer a range of products, including the Momentum product line which includes portable mass spectrometers and gas chromatographs. They also provide the ZipChip system for protein analysis. 908 Devices focuses on specific industries such as life sciences, chemistry, security and defense, and energy. Their devices offer improved mobility, flexibility, and efficiency compared to traditional analysis methods. Their customers include pharmaceutical and biotech companies, research institutions, and regulatory authorities. 908 Devices' unique business model is based on portable devices and advanced technologies tailored to specific industry needs.

odotettu liikevaihto 908 Devices on 68,53 M USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.

odotettu voitto 908 Devices on −14,48 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.

908 Devices:n hinta-voitto-suhde (P/E) on tällä hetkellä −20,49. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan 908 Devices-osakkeen arvostusta.

908 Devices:n hinta-myynti-suhde (P/S) on tällä hetkellä 4,33. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii 908 Devices-osakkeen arvostuskennuslukuna.

908 Devices:n Eulpool-laatuscore on 3/10.

908 Devices:n ISIN on US65443P1021. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

908 Devices:n WKN on A2QK1S. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.

908 Devices:n ticker on MASS. Tämä pörssinoteeraus käytetään 908 Devices-osakkeiden kauppaan pörssissä.

908 Devices maksoi osinkoa joka vuosi viimeisten 0 vuoden aikana.

908 Devices kuuluu sektoriin 'Informaatioteknologia'.

908 Devices:n osingot jaetaan valuutassa USD.